EUVIMEDEUVIMED entdecken
Crossref

An integrated centrifugal microfluidic CRISPR-based diagnostics platform for multiplexed point-of-care testing of respiratory pathogens

Lingyun Li, Hongjuan Wei, Muyun Wei, Xingsheng Yang, Tianci Wang, Shengping Min, Yunxiang Wang, Xiaojing Wang, Min Li, Shengqi Wang, Zhen Rong

Biosensors and Bioelectronics · 2026-11 · 312 · 119083

DOI: 10.1016/j.bios.2026.119083 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2026-11. Verfasst von Lingyun Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Bioinformatics Center of AMMS, Beijing, 100850, PR China. Hauptthemen laut MEDLINE: Biosensing Techniques, Point-of-Care Testing, CRISPR-Cas Systems, Respiratory Tract Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Beijing Nova Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rapid, accurate, and multiplexed point-of-care testing (POCT) of respiratory pathogens is critical for clinical triage and infection control. However, existing platforms frequently necessitate trade-offs between sensitivity, throughput, and operational complexity. To address this, we developed the iCARD (integrated Centrifugal Assay on a Rotating Disc) platform, a streamlined microfluidic molecular diagnostic system based on single-step CRISPR kinetics and centrifugal microfluidics. Comprising a polymethyl methacrylate disc pre-loaded with lyophilized CRISPR/Cas13a reagents and a self-developed portable fluorescence analyzer, the platform enables automated multiplexed detection following sample loading. Furthermore, a novel resin-based pretreatment method was engineered to efficiently purify and concentrate nucleic acids from throat swabs. The iCARD system facilitates the parallel screening of six respiratory pathogens across four independent samples within 40 min. Analytical validation confirmed single-copy sensitivity (limit of detection: 0.25-1.0 copies/μL) without cross-reactivity. Clinical validation using 94 retrospective patient throat swabs demonstrated exceptional diagnostic accuracy, achieving a sensitivity of 95.5% (64/67; 95% CI: 87.64%-98.47%) and a specificity of 100.0% (27/27; 95% CI: 87.51%-100.00%). These findings demonstrate that the iCARD platform serves as a robust, high-throughput, and accurate diagnostic tool for decentralized molecular screening and epidemiological surveillance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biosensing TechniquesPoint-of-Care TestingCRISPR-Cas SystemsRespiratory Tract InfectionsMicrofluidic Analytical TechniquesHumansEquipment DesignLab-On-A-Chip DevicesCentrifugationLimit of DetectionRapid Diagnostic TestsPoint-of-Care Systems

Stichwörter der Autor:innen

CRISPRCentrifugal microfluidic chipPoint-of-care testingResin-based reverse enrichment methodRespiratory pathogens

Autor:innen und Institutionen

  • Bioinformatics Center of AMMS, Beijing, 100850, PR China.
  • Department of Laboratory Medicine, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital, Shanghai, 200127, PR China.
  • Anhui Province Key Laboratory of Respiratory Tumor and Infectious Disease, Molecular Diagnosis Center, Department of Pulmonary Critical Care Medicine, The First Affiliated Hospital of Bengbu Medical University, Bengbu,…
  • Department of Laboratory Medicine, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital, Shanghai, 200127, PR China. Electronic address: rjlimin@shsmu.edu.cn.
  • Bioinformatics Center of AMMS, Beijing, 100850, PR China. Electronic address: sqwang@bmi.ac.cn.
  • Bioinformatics Center of AMMS, Beijing, 100850, PR China. Electronic address: rongzhen0525@163.com.

Förderung

  • National Natural Science Foundation of China
  • Beijing Nova Program

Zitieren

APA

Li, L., Wei, H., Wei, M., Yang, X., Wang, T., Min, S., Wang, Y., Wang, X., Li, M., Wang, S., & Rong, Z. (2026). An integrated centrifugal microfluidic CRISPR-based diagnostics platform for multiplexed point-of-care testing of respiratory pathogens. Biosensors and Bioelectronics, 312, 119083. https://doi.org/10.1016/j.bios.2026.119083

Vancouver

Li L, Wei H, Wei M, Yang X, Wang T, Min S, et al. An integrated centrifugal microfluidic CRISPR-based diagnostics platform for multiplexed point-of-care testing of respiratory pathogens. Biosensors and Bioelectronics. 2026;312:119083. doi:10.1016/j.bios.2026.119083

BibTeX
@article{Li2026,
  author = {Li, Lingyun and Wei, Hongjuan and Wei, Muyun and Yang, Xingsheng and Wang, Tianci and Min, Shengping and Wang, Yunxiang and Wang, Xiaojing and Li, Min and Wang, Shengqi and Rong, Zhen},
  title = {An integrated centrifugal microfluidic CRISPR-based diagnostics platform for multiplexed point-of-care testing of respiratory pathogens},
  journal = {Biosensors and Bioelectronics},
  year = {2026},
  volume = {312},
  pages = {119083},
  doi = {10.1016/j.bios.2026.119083}
}
Kostenlos starten →